CoChat
Sign Up
Cited by 3Psychedelics and Drug StudiesPosttraumatic Stress Disorder ResearchHealth Systems, Economic Evaluations, Quality of Life

Correction: Updated cost-effectiveness of MDMA-assisted therapy for the treatment of posttraumatic stress disorder in the United States: Findings from a phase 3 trial

Open access
Marseille, Elliot, Mitchell, Jennifer M., Kahn, James G.·2022·PLOS ONE
DOI 10.1371/journal.pone.0269623PMC PMC9162307
Open this paper in CoChat — free accountOpen PDF

Abstract

[This corrects the article DOI: 10.1371/journal.pone.0263252.].

Integrity signals

Registry

Crossref · 10.1371/journal.pone.0269623

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • A recent study on MDMA-assisted therapy for PTSD reported that >90% of intervention costs were due to clinician compensation.

    “A recent study on 3,4-methylenedioxymethamphetamine (MDMA)-assisted therapy for posttraumatic stress disorder reported that >90% of intervention costs were due to clinician compensation, 18”

    From Innovations in group-based psilocybin-assisted therapy of major depression in patients with cancer (2024) · cites this paper as [18]

Cites

Flagged first, then by citations

Authors
Marseille, E., Mitchell, J. M., & Kahn, J. G.
ORCID
Venue
PLOS ONE
Publisher
Public Library of Science (PLoS)
Published
2022-06-02
Volume
17
Issue
6
Pages
e0269623
ISSN
1932-6203 (ISSN-L)
DOI
10.1371/journal.pone.0269623
PMC
PMC9162307
OpenAlex
W4281994902
Cited by
3
References
1
Citations by year
2024: 1 · 2023: 1 · 2022: 1
Type
journal article
Language
en
Open access
Licence
Locations
  • PLoS ONE (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Topics
  • Social Sciences › Psychology › Clinical Psychology › Psychedelics and Drug Studies
  • Social Sciences › Psychology › Clinical Psychology › Posttraumatic Stress Disorder Research
  • Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Health Systems, Economic Evaluations, Quality of Life
Keywords
MDMA-assisted psychotherapy, post-traumatic stress disorder, cost-effectiveness, MDMA

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review